Investigator Web site Community Continues to Increase Community Measurement and Affected person Attain with Acquisition of Multi-Specialty Medical Analysis Middle
ORLANDO, FLA. – 9 April 2024 – Alcanza Medical Analysis, a mission-focused investigator web site community, has acquired Innovation Medical Analysis Middle (Innovation), a multi-specialty scientific analysis middle. This deal is a key a part of Alcanza’s progress technique, marking the ninth acquisition since 2021, and enabling the positioning community to develop its therapeutic space capabilities and variety of research individuals.
Positioned in Palmetto Bay, Fla., Innovation conducts Section I to Section IV scientific trials in key therapeutic areas comparable to cardiology, dermatology, endocrinology, gastroenterology, infectious illness, inside drugs, nephrology, neurology, psychiatry, rheumatology, and girls’s well being.
“As Alcanza continues to develop, the addition of Innovation strengthens our capabilities in a wide range of high-growth therapeutic areas,” mentioned Carlos Orantes, CEO, Alcanza. “Moreover, the middle’s prime location permits us to achieve new, various affected person populations, aligning with our mission to make scientific analysis accessible to everybody.”
“Becoming a member of a longtime web site community, comparable to Alcanza, whose mission and values are intently aligned with ours, is significant to the continued progress and success of Innovation,” mentioned Omar Orama, Web site Director.
About Alcanza Medical Analysis:
Alcanza is an built-in community of analysis amenities devoted to decreasing boundaries to scientific analysis participation, particularly in underrepresented affected person populations. The community consists of 20 devoted analysis items and 16 extra websites built-in inside specialty clinics. These amenities are strategically positioned throughout the Southeast, Northeast, and Midwest areas of the USA. Alcanza helps research that span all trial phases and main therapeutic areas. www.AlcanzaClinical.com.
Media Contact:
Karen Hagens
KTH Communications
Karen@KTHcomms.com